PREVENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS; TASK ORDER TITLE: PRECLINICAL DEVELOPMENT OF AN RNA VACCINE FOR IMMUNOPREVENTION OF ...

From: Federal Procurement Data System(Federal)
TORFP 2020 E-06

Basic Details

started - 08 Sep, 2020 (about 3 years ago)

Start Date

08 Sep, 2020 (about 3 years ago)
due - 07 Jan, 2025 (in 8 months)

Due Date

07 Jan, 2025 (in 8 months)
Contract

Type

Contract
TORFP 2020 E-06

Identifier

TORFP 2020 E-06
NATIONAL INSTITUTES OF HEALTH

Customer / Agency

NATIONAL INSTITUTES OF HEALTH
unlockUnlock the best of InstantMarkets.

Please Sign In to see more out of InstantMarkets such as history, intelligent business alerts and many more.

Don't have an account yet? Create a free account now.

PREVENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS; TASK ORDER TITLE: PRECLINICAL DEVELOPMENT OF AN RNA VACCINE FOR IMMUNOPREVENTION OF PROSTATE CANCER
Solicitation ID/Procurement Identifier: TORFP 2020 E-06
Ultimate Completion Date: Tue Jan 07 18:00:00 GMT

ILLINOIS,USA,606163717Location

Address: ILLINOIS,USA,606163717

Country : United StatesState : Illinois

You may also like

AMA ONCOTYPE PROSTATE CANCER TESTING

Due: 02 Apr, 2025 (in 11 months)Agency: VETERANS AFFAIRS, DEPARTMENT OF

CONDUCT A PHASE 2B EFFICACY STUDY AS PRESCRIBED IN AOI15 WITH COVILIV A PROPRIETARY LIVE ATTENUATED VIRUS COVID-19 VACCINE.

Due: 30 Sep, 2026 (in about 2 years)Agency: OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE

Please Sign In to see more like these.

Don't have an account yet? Create a free account now.

Classification

RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)/541714